SUPPLEMENTARY MATERIAL - Sustained hair regrowth with continued ritlecitinib treatment through Week 48 in patients with alopecia areata with or without early target responses: post hoc analysis of the ALLEGRO phase 2b/3 trial

Published: 9 October 2024| Version 1 | DOI: 10.17632/r34sk3mg2r.1
Contributor:
Liza Takiya

Description

Supplemental Data, Plain Language Summary, and Video Abstract to accompany article: Piliang et al., Sustained hair regrowth with continued ritlecitinib treatment through Week 48 in patients with alopecia areata with or without early target responses: post hoc analysis of the ALLEGRO phase 2b/3 trial

Files

Categories

Alopecia, Management of Alopecia Symptom, Alopecia Areata, Janus Kinase

Licence